Kalaris Therapeutics, Inc. (KLRS): Depreciation & Amortization
Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$398.0K
Year ended 2023-12-31
+76.0%
3-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $398.0K | -45.0% | 2025-03-07, From 2023-01-01 |
| 2022-12-31 | $723.0K | +282.5% | 2024-03-15, From 2022-01-01 |
| 2021-12-31 | $189.0K | +158.9% | 2023-02-15, From 2021-01-01 |
| 2020-12-31 | $73.0K | +284.2% | 2022-02-10, From 2020-01-01 |
| 2019-12-31 | $19.0K | n/a | 2021-02-12, From 2019-01-01 |